CNO

#1331
CNO Financial Group, Inc. Common Stock
54.8 2 USD
-0.01%
Market Price
Sektor: Finanzen
Basis: USD
Gewinnwährung: USD
Tagesspanne
54.66
54.87
Jahresspanne
38.22
57.30
Tagesänderung
-0.98%
Monatliche Änderung
-1.39%
6 month change
+30.34%
Jahresänderung
+40.64%
Vorheriger Schlusskurs
55.3 6
Open
54.7 1
Tief
54.6 6
Hoch
54.8 7
Volumen
369
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden Documents

2026

Current report, Q3 FY2026
CNO Financial Group, Inc. current report, Q3 FY2026
8-K
Institutional holdings, Q2 FY2026
CNO Financial Group, Inc. institutional holdings, Q2 FY2026
13F-HR
Quarterly report, Q2 FY2026
CNO Financial Group, Inc. quarterly report, Q2 FY2026
10-Q
INFORMATION TABLE, Q2 FY2026
CNO Financial Group, Inc. INFORMATION TABLE, Q2 FY2026
INFORMATION TABLE
Current report, Q2 FY2026
CNO Financial Group, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
CNO Financial Group, Inc. current report, Q2 FY2026
8-K
Institutional holdings, Q1 FY2026
CNO Financial Group, Inc. institutional holdings, Q1 FY2026
13F-HR
Quarterly report, Q1 FY2026
CNO Financial Group, Inc. quarterly report, Q1 FY2026
10-Q
INFORMATION TABLE, Q1 FY2026
CNO Financial Group, Inc. INFORMATION TABLE, Q1 FY2026
INFORMATION TABLE
Current report, Q1 FY2026
CNO Financial Group, Inc. current report, Q1 FY2026
8-K

CNO Financial Group, Inc. INFORMATION TABLE, Q4 FY2014

Full document

CNO Financial Group, Inc. - Form 13F Summary

Business Context and Reporting Period

This filing is a Form 13F Information Table submitted by CNO Financial Group, Inc. for the reporting period ending December 31, 2014. The document discloses the investment manager's holdings in equity securities and certain debt instruments as of the period end.

Key Financial Metrics and Holdings

The filing details a portfolio of 16 positions with a total reported value of approximately $355,280,000 (sum of Column 4 values). The portfolio composition includes:

  • Equity Holdings: Significant positions in Ford Motor Co. (87,514 shares), EMC Corp (19,329 shares), and various ETFs including SPDR S&P 500 ETF (559,925 shares) and iShares Core US Aggregate Bond ETF (823,500 shares).
  • Debt/Principal Holdings: Large principal amounts in Bristol-Myers Squibb Co. ($1,000,000), Danaher Corp ($1,000,000), Gilead Sciences Inc. ($500,000), and Welltower Inc. ($1,500,000).
  • Voting Authority: CNO Financial Group, Inc. reported Sole voting authority for all listed positions.

Note: This filing does not contain revenue, profit, cash flow, margin, or liquidity data for CNO Financial Group, Inc. itself, as Form 13F is a disclosure of assets held, not a financial performance report.

Material Changes

The filing text provided does not contain comparative data from the prior quarter or year. Therefore, material changes in holdings versus the prior comparable period cannot be determined from this document alone.

Guidance, Outlook, and Risks

The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a statutory disclosure of securities held.

Investor Verification Checklist

  • Verify the total portfolio value by summing the "Value" column (Column 4) to confirm the aggregate exposure.
  • Confirm the distinction between share counts (Column 2) and principal amounts (Column 3) for debt instruments versus equity shares.
  • Check subsequent filings to determine if these positions were maintained, increased, or liquidated in the following quarter.
  • Review the specific CUSIP numbers to ensure accurate identification of the securities, particularly for the debt instruments listed.